Status:
UNKNOWN
Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal Cancers
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Collaborating Sponsors:
Academia Sinica, Taiwan
Conditions:
Colorectal Cancers
Eligibility:
All Genders
20-90 years
Phase:
PHASE1
Brief Summary
Recent basic and clinical research on the circulating tumor cells (CTCs) in CRC patients takes potential diagnostics, prognostics, and applications into consideration, especially the molecular detecti...
Detailed Description
Colorectal cancer (CRC) is one of the most frequent malignancies and is also the third major cause of cancer-related death in Taiwan, with over 11,000 new cases of CRC were diagnosed and more than 4,4...
Eligibility Criteria
Inclusion
- Age \> 18 y/o
- Histological / pathologic and image study proved colorectal cancer
- Patients with adequate tissue for biomarkers analysis
- Patients voluntary sign informed consent
Exclusion
- Patients who are not met with either one of items which mentioned above.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01828918
Start Date
June 1 2012
End Date
December 1 2016
Last Update
April 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Hospital
Kaohsiung City, Kaohsiung, Taiwan, 807